Single-dose pharmacokinetics of ofloxacin during continuous venovenous hemofiltration in critical care patients

American Journal of Kidney Diseases

Volumn 42, Issue 2, 2003, Pages 310-314

  Fuhrmann, Valentin ^b   Schenk, Peter ^a   Mittermayer, Christoph ^b   El Menyawi, Ibrahim ^b   Ratheiser, Klaus ^b   Thalhammer, Florian ^b  

^a UNIVERSITY OF VIENNA   (Austria)

^b NONE

Author keywords

Continuous venovenous hemofiltration (CVVH); Multiple organ failure; Ofloxacin; Pharmacokinetics; Polysulfone capillary hemofilter; Renal replacement therapy (RRT)

Indexed keywords

OFLOXACIN; POLYSULFONE;

ACUTE KIDNEY FAILURE; ADULT; AGED; ANURIA; ARTICLE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DETERMINATION; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; HEMOFILTRATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTENSIVE CARE; MALE; MEASUREMENT; MEMBRANE FILTER; TIME; ULTRAFILTRATION; VENOUS BLOOD;

EID: 0041626019     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(03)00656-5     Document Type: Article

References (31)

1. Monk JP, Campoli-Richards DM: Ofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs 33:346-391, 1987
2. Lode H, Hoffken G, Olschewski P, et al: Pharmacokinetics of ofloxacin after parenteral and oral administration. Antimicrob Agents Chemother 31:1338-1342, 1987
3. Fillastre JP, Leroy A, Humbert G: Ofloxacin pharmacokinetics in renal failure. Antimicrob Agents Chemother 31:156-160, 1987
4. Lameire N, Rosenkranz B, Malerczyk V, Lehr KH, Veys N, Ringoir S: Ofloxacin pharmacokinetics in chronic renal failure and dialysis. Clin Pharmacokinet 21:357-371, 1991
5. Ronco C, Bellomo R: Basic mechanisms and definitions for continuous renal replacement therapies. Int J Artif Organs 19:95-99, 1996
6. van der Werf TS, Mulder PO, Zijlstra JG, Uges DR, Stegeman CA: Pharmacokinetics of piperacillin and tazobactam in critically ill patients with renal failure, treated with continuous veno-venous hemofiltration (CVVH). Intensive Care Med 23:873-877, 1997
7. Ronco C, Bellomo R, Homel P, et al: Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: A prospective randomised trial. Lancet 356:26-30, 2000
8. Cotterill S: Antimicrobial prescribing in patients on haemofiltration. J Antimicrob Chemother 36:773-780, 1995
9. Thalhammer F, Schenk P, Burgmann H, et al: Single-dose pharmacokinetics of meropenem during continuous venovenous hemofiltration. Antimicrob Agents Chemother 42:2417-2420, 1998
10. Canaud B, Garred LJ, Christol JP, Aubas S, Beraud JJ, Mion C: Pump assisted continuous venovenous hemofiltration for treating acute uremia. Kidney Int Suppl 24:S154-S156, 1988
11. Thalhammer F, Kletzmayr J, El Menyawi I, et al: Ofloxacin clearance during hemodialysis: A comparison of polysulfone and cellulose acetate hemodialyzers. Am J Kidney Dis 32:642-645, 1998
12. Thalhammer F, Schmaldienst S, Elmenyawi I, et al: Multiple-dose pharmacokinetics of cefpirome in long-term hemodialysis with high-flux membranes. Clin Pharmacol Ther 60:645-650, 1996
13. Golper TA: Drug removal during continuous hemofiltration or hemodialysis. Contrib Nephrol 93:110-116, 1991
14. Schetz M, Ferdinande P, Van den Berghe G, Verwaest C, Lauwers P: Pharmacokinetics of continuous renal replacement therapy. Intensive Care Med 21:612-620, 1995
15. Armstrong DK, Hodgman T, Visconti JA, Reilley TE, Garner WL, Dasta JF: Hemodialysis of amikacin in critically ill patients. Crit Care Med 16:517-520, 1988
16. Thalhammer F, Rosenkranz AR, Burgmann H, et al: Single-dose pharmacokinetics of teicoplanin during hemodialysis therapy using high-flux polysulfone membranes. Wien Klin Wochenschr 109:362-365, 1997
17. Agarwal R, Cronin RE: Heterogeneity in gentamicin clearance between high-efficiency hemodialyzers. Am J Kidney Dis 23:47-51, 1994
18. Schuster H, Neeser G, Hehenberger H, Lichtwarck M, Zichner M, Eckart J: Pharmacokinetics of ofloxacin in patients with acute renal failure undergoing haemofiltration. Drugs 45:S267-S268, 1993 (suppl 3)
19. Traunmuller F, Thalhammer-Scherrer R, Locker GJ, et al: Single-dose pharmacokinetics of levofloxacin during continuous veno-venous haemofiltration in critically ill patients. J Antimicrob Chemother 47:229-231, 2001
20. Guenter SG, Iven H, Boos C, Bruch HP, Muhl E: Pharmacokinetics of levofloxacin during continuous venovenous hemodiafiltration and continuous venovenous hemofiltration in critically ill patients. Pharmacotherapy 22:175-183, 2002
21. Bellmann R, Egger P, Gritsch W, et al: Elimination of levofloxacin in critically ill patients with renal failure: Influence of continuous veno-venous hemofiltration. Int J Clin Pharmacol Ther 40:142-149, 2002
22. Golper TA: Update on drug sieving coefficients and dosing adjustments during continuous renal replacement therapies. Contrib Nephrol 132:349-353, 2001
23. Bugge JF: Pharmacokinetics and drug dosing adjustments during continuous venovenous hemofiltration or hemodiafiltration in critically ill patients. Acta Anaesthesiol Scand 45:929-934, 2001
24. Golper TA, Marx MA: Drug dosing adjustments during continuous renal replacement therapies. Kidney Int Suppl 66:S165-S168, 1998
25. Rumpf KW, Rieger J, Ansorg R, Doht B, Scheler F: Binding of antibiotics by dialysis membranes and its clinical relevance. Proc Eur Dial Transplant Assoc 14:607-609, 1977
26. Kronfol NO, Lau AH, Barakat MM: Aminoglycoside binding to polyacrylonitrile hemofilter membranes during continuous hemofiltration. ASAIO Trans 33:300-303, 1987
27. Oborne CA, Buckton G, Barber N: The interaction of albumin and drugs with two haemofiltration membranes. J Clin Pharm Ther 19:119-125, 1994
28. Flor S: Pharmacokinetics of ofloxacin. An overview. Am J Med 87: S24-S30, 1989 (suppl 6C)
29. Dorfler A, Schulz W, Burkhardt F, Zichner M: Pharmacokinetics of ofloxacin in patients on haemodialysis treatment. Drugs 34:S62-S70, 1987 (suppl 1)
30. Bandai H, Tsubakihara Y, Yamato E, et al: Pharmacokinetics of ofloxacin in severe chronic renal failure. Clin Ther 11:210-218, 1989
31. Kampf D, Borner K, Pustelnik A: Multiple dose kinetics of ofloxacin and ofloxacin metabolites in haemodialysis patients. Eur J Clin Pharmacol 42:95-99, 1992